Severely low testosterone in males with COVID‐19: A case‐control study
Andrology2021Vol. 9(4), pp. 1043–1052
Citations Over TimeTop 1% of 2021 papers
Andrea Salonia, Marina Pontillo, Paolo Capogrosso, Silvia Gregori, Michela Tassara, Luca Boeri, Cristina Carenzi, Costantino Abbate, Daniele Cignoli, Anna Maria Ferrara, Walter Cazzaniga, Isaline Rowe, Giuseppe A. Ramirez, Cristina Tresoldi, Junaid Mushtaq, Massimo Locatelli, Luca Santoleri, Antonella Castagna, Alberto Zangrillo, Francesco De Cobelli, Moreno Tresoldi, Giovanni Landoni, Patrizia Rovere‐Querini, Fabio Ciceri, Francesco Montorsi
Abstract
We unveil an independent association between SARS-CoV-2 infection status and secondary hypogonadism already at hospital admission, with lower testosterone levels predicting the most severe clinical outcomes.
Related Papers
- → Comorbidity in head and neck cancer: A critical appraisal and recommendations for practice(2010)238 cited
- → Elderly patients with head and neck cancer: the influence of comorbidity on choice of therapy, complication rate, and survival(2005)66 cited
- → Health Care Resource Utilization And Costs Associated With HIV-Positive Patients With Comorbidity Versus HIV-Negative Patients With Comorbidity(2017)4 cited
- Influence of comorbidity on the choice of treatment and survival of elderly patients with advanced non-small cell lung cancer(2008)
- → Comorbidity Index(2017)